NCT00343382 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- End of 6 Weeks
- Other-event reporting threshold
- 0%
Adverse event information at end of 6 weeks is not available on one participant from collective placebo arm.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Pilocarpine 2 Times Per Day | 0 / 65 | 48 / 65 | Not reported / Not reported |
| Pilocarpine 4 Times Per Day | 0 / 66 | 47 / 66 | Not reported / Not reported |
| Collective Placebo | 0 / 63 | 33 / 63 | Not reported / Not reported |
Serious adverse events
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 65
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Flashing vision
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 65
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 65
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 66
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 65
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- term
- Dry mouth
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 65
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Flatulence
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 65
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 66
- num Events
- 3
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- term
- Gastrointestinal disorder
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 65
- num Events
- 16
- group Id
- EG001
- num Affected
- 20
- num At Risk
- 66
- num Events
- 20
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 63
- num Events
- 7
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 65
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 66
- num Events
- 2
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Salivary gland disorder
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 65
- num Events
- 14
- group Id
- EG001
- num Affected
- 17
- num At Risk
- 66
- num Events
- 17
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 63
- num Events
- 2
- term
- Rigors
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 65
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- General symptom
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 65
- num Events
- 10
- group Id
- EG001
- num Affected
- 13
- num At Risk
- 66
- num Events
- 13
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 63
- num Events
- 6
- term
- Dizziness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 65
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Headache
Complete source fields
- description
- Adverse event information at end of 6 weeks is not available on one participant from collective placebo arm.
- event Groups
- description
- Patients receive 5mg of Pilocarpine 2 times per day for 6 weeks.
- id
- EG000
- other Num Affected
- 48
- other Num At Risk
- 65
- serious Num Affected
- 0
- serious Num At Risk
- 65
- title
- Pilocarpine 2 Times Per Day
- description
- Patients receive 5mg of Pilocarpine 4 times per day for 6 weeks.
- id
- EG001
- other Num Affected
- 47
- other Num At Risk
- 66
- serious Num Affected
- 0
- serious Num At Risk
- 66
- title
- Pilocarpine 4 Times Per Day
- description
- Patients receive 1 capsule of placebo 2 times per day for 6 weeks and; patients receive 1 capsule of placebo 4 times per day for 6 weeks.
- id
- EG002
- other Num Affected
- 33
- other Num At Risk
- 63
- serious Num Affected
- 0
- serious Num At Risk
- 63
- title
- Collective Placebo
- frequency Threshold
- 0
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 65
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Flashing vision
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 65
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Abdominal distension
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 65
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 66
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 65
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- term
- Dry mouth
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 65
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Flatulence
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 65
- num Events
- 0
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 66
- num Events
- 3
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 63
- num Events
- 1
- term
- Gastrointestinal disorder
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 65
- num Events
- 16
- group Id
- EG001
- num Affected
- 20
- num At Risk
- 66
- num Events
- 20
- group Id
- EG002
- num Affected
- 7
- num At Risk
- 63
- num Events
- 7
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 65
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 66
- num Events
- 2
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Salivary gland disorder
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 65
- num Events
- 14
- group Id
- EG001
- num Affected
- 17
- num At Risk
- 66
- num Events
- 17
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 63
- num Events
- 2
- term
- Rigors
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 65
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- General symptom
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 65
- num Events
- 10
- group Id
- EG001
- num Affected
- 13
- num At Risk
- 66
- num Events
- 13
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 63
- num Events
- 6
- term
- Dizziness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- CTCAEV3.0
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 65
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 66
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 63
- num Events
- 0
- term
- Headache
- time Frame
- End of 6 Weeks
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle